Peer-reviewed veterinary case report
Dog with pemphigus vulgaris skin disease helped by oclacitinib
By Martinez, Nicola et al.·Published in Veterinary Dermatology·2022·The University Veterinary Teaching Hospital of Sydney Sydney Australia, Australia·View original on Crossref →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: A case report of the beneficial effect of oclacitinib in a dog with pemphigus vulgaris
- Species:
- dog
Plain-English summary
A 5-year-old female dog was diagnosed with pemphigus vulgaris, a serious skin condition where the immune system attacks the skin, causing painful sores and blisters. Traditional treatments often involve strong immunosuppressive medications, but in this case, the dog was successfully treated with oclacitinib, along with a topical medication containing fucidic acid and betamethasone valerate. This combination helped to reduce the skin lesions and improve the dog's overall condition. The dog showed significant improvement and was more comfortable after starting the new treatment.
People also search for: dog pemphigus vulgaris treatment · oclacitinib for dogs · dog skin sores medication
Abstract
Pemphigus vulgaris is a rare immune‐mediated skin disorder of the dog, usually treated with immunosuppressive medications such as oral glucocorticoids, azathioprine or ciclosporin. Herein we report the successful treatment of pemphigus vulgaris in a dog, using oclacitinib and a topical product containing fucidic acid (0.5 % w/w) and betamethasone valerate.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Crossref: https://doi.org/10.1111/vde.13063